Calren Care Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.25 M
as on 16-12-2024
- Revenue 61.17%
(FY 2023)
- Profit 161.38%
(FY 2023)
- Ebitda 169.48%
(FY 2023)
- Net Worth 88.01%
(FY 2023)
- Total Assets 64.24%
(FY 2023)
About Calren Care Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.25 M.
Ram and Chandrakanth Balkatte serve as directors at the Company.
- CIN/LLPIN
U24297TG2015PTC101366
- Company No.
101366
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Calren Care Lifesciences Private Limited offer?
Calren Care Lifesciences Private Limited offers a wide range of products and services, including Health Conditions, Stomach Care, Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Calren Care Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram  | Director | 17-Jun-2019 | Current |
| Chandrakanth Balkatte | Director | 29-May-2017 | Current |
Financial Performance of Calren Care Lifesciences.
Calren Care Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.17% increase. The company also saw a substantial improvement in profitability, with a 161.38% increase in profit. The company's net worth Soared by an impressive increase of 88.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Calren Care Lifesciences?
Unlock access to Calren Care Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 23 Feb 2021 | ₹0.50 M | Open |
Canara Bank Creation Date: 29 Feb 2020 | ₹0.75 M | Open |
Canara Bank Creation Date: 30 Dec 2019 | ₹5.00 M | Open |
How Many Employees Work at Calren Care Lifesciences?
Unlock and access historical data on people associated with Calren Care Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Calren Care Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calren Care Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
